4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000039
CEO bought 52,000 shares at an average $0.01 ($636)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-06-13 | Purchase : show line 1 in the form | +11,000 | $0.01 | $131 | 24,313,097 | D |
| 2019-06-13 | Purchase : show line 2 in the form | +11,000 | $0.01 | $133 | 24,324,097 | D |
| 2019-06-14 | Purchase : show line 3 in the form | +11,000 | $0.01 | $134 | 24,335,097 | D |
| 2019-06-17 | Purchase : show line 4 in the form | +2,000 | $0.01 | $26 | 24,337,097 | D |
| 2019-06-17 | Purchase : show line 5 in the form | +5,000 | $0.01 | $62 | 24,342,097 | D |
| 2019-06-17 | Purchase : show line 6 in the form | +5,000 | $0.01 | $63 | 24,347,097 | D |
| 2019-06-17 | Purchase : show line 7 in the form | +5,000 | $0.01 | $62 | 24,352,097 | D |
| 2019-06-17 | Purchase : show line 8 in the form | +2,000 | $0.01 | $25 | 24,354,097 | D |
| Open-market purchases · 52,000 sh · avg $0.01 · $636 | ||||||
Loading xslF345X03/primary_doc.xml…